Duopharma Biotech Bhd
KLSE:DPHARMA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
D
|
Duopharma Biotech Bhd
KLSE:DPHARMA
|
MY |
|
Lumentum Holdings Inc
NASDAQ:LITE
|
US |
|
F
|
Focus Minerals Ltd
XMUN:FZA
|
AU |
|
E
|
Eli Lilly and Co
F:LLY
|
US |
|
United Bankers Oyj
F:DX0
|
FI |
|
L
|
Linde PLC
F:LIN
|
UK |
|
A
|
Avient Corp
F:PY9
|
US |
Intrinsic Value
Is DPHARMA undervalued or overvalued?
See the intrinsic value estimate for Duopharma Biotech Bhd and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
DPHARMA looks undervalued.
But is it cheap by its own standards?
See how today’s valuation compares with DPHARMA’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Duopharma Biotech Bhd Does
Duopharma Biotech Bhd is a Malaysian pharmaceutical company that makes and sells prescription medicines, over-the-counter health products, and some biologic and biosimilar drugs. It develops, manufactures, markets, and distributes these products under its own brands and also through contract manufacturing for other companies. Its business sits in the middle of the healthcare supply chain: it turns drug formulas into finished products that pharmacies, hospitals, clinics, and distributors can buy and pass on to patients.
- Headquarters
- Malaysia MY
- Employees
- 2 001
- IPO date
- Jul 18, 2002
Revenue & Expenses Breakdown
Duopharma Biotech Bhd
Earnings Waterfall
Duopharma Biotech Bhd
The intrinsic value for Duopharma Biotech Bhd (DPHARMA) under the Base Case is hidden MYR.
Compared with the current market price of 1.09 MYR, the stock appears hidden.